CBD Life Sciences Inc. (CBDL) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
CBDL Profit Margin, ROE & Profitability Analysis
CBDL vs Materials Sector: How CBD Life Sciences Inc. Compares
How CBD Life Sciences Inc. compares to Materials sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is CBD Life Sciences Inc. Stock Overvalued? CBDL Valuation Analysis 2026
Based on fundamental analysis, CBD Life Sciences Inc. has mixed fundamental signals relative to the Materials sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
CBD Life Sciences Inc. Balance Sheet: CBDL Debt, Cash & Liquidity
CBDL Revenue Growth, EPS Growth & YoY Performance
CBDL SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for CBD Life Sciences Inc. (CIK: 0001776073)
❓ Frequently Asked Questions about CBDL
What is the AI rating for CBDL?
CBD Life Sciences Inc. (CBDL) has an AI grade of N/A with 0% confidence, based on fundamental analysis of SEC EDGAR filings.
What are CBDL's key strengths?
Claude: Analysis in progress.
What are the risks of investing in CBDL?
Claude: Analysis in progress.
What is CBDL's revenue and growth?
CBD Life Sciences Inc. reported revenue of N/A.
Does CBDL pay dividends?
CBD Life Sciences Inc. does not currently pay dividends.
Where can I find CBDL SEC filings?
Official SEC filings for CBD Life Sciences Inc. (CIK: 0001776073) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CBDL's EPS?
CBD Life Sciences Inc. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is CBDL's fundamental grade?
Based on our AI fundamental analysis in July 2026, CBD Life Sciences Inc. has a N/A grade with 0% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is CBDL stock overvalued or undervalued?
Valuation metrics for CBDL: ROE of N/A (sector avg: 14%), net margin of N/A (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
What is CBDL's AI grade for 2026?
Our dual AI analysis gives CBD Life Sciences Inc. a combined N/A grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is CBDL's free cash flow?
CBD Life Sciences Inc.'s operating cash flow is N/A, with capital expenditures of N/A.
How does CBDL compare to other Materials stocks?
Vs Materials sector averages: Net margin N/A (avg: 10%), ROE N/A (avg: 14%), current ratio N/A (avg: 1.6).